The veterinary point of care diagnostics market size has grown rapidly in recent years. It will grow from $2.01 billion in 2025 to $2.28 billion in 2026 at a compound annual growth rate (CAGR) of 13.4%. The growth in the historic period can be attributed to rising prevalence of infectious and metabolic diseases in animals, growth of veterinary clinics and hospitals, increasing awareness of animal health, advancements in diagnostic reagents and kits, rising companion animal population.
The veterinary point of care diagnostics market size is expected to see rapid growth in the next few years. It will grow to $3.75 billion in 2030 at a compound annual growth rate (CAGR) of 13.3%. The growth in the forecast period can be attributed to adoption of portable diagnostic analyzers, integration of AI and IoT in veterinary diagnostics, growth in home care veterinary solutions, increasing investment in veterinary point-of-care R&D, expansion of molecular and biochemical diagnostic technologies. Major trends in the forecast period include increasing adoption of rapid diagnostic tools, rising demand for on-site testing solutions, expansion of companion animal health monitoring, integration of real-time data in veterinary care, growth of preventive veterinary diagnostics.
The rising companion animal population is expected to drive growth in the veterinary point-of-care diagnostics market in the coming years. Companion animals are pets that live in close proximity to humans. The increase in companion animal numbers is boosting demand for veterinary point-of-care diagnostics, which enable faster clinical decision-making in diagnosis, treatment selection, monitoring, prognosis, as well as operational and resource management. Veterinary point-of-care diagnostics support the companion animal population by providing rapid and accurate health assessments, allowing timely treatment and improved overall care. For example, in March 2025, according to the American Pet Products Association, a US-based national pet products trade organization, 94 million U.S. households owned at least one pet, up from 82 million in 2023, reflecting a significant rise in companion animal adoption. Therefore, the growing companion animal population is propelling the veterinary point-of-care diagnostics market.
Leading players in the veterinary point-of-care diagnostics market are developing innovative assays to maintain a competitive edge. Assays are diagnostic tests designed to detect specific biological markers, substances, or conditions associated with particular diseases. For instance, in September 2023, Zomedica Corp., a US-based veterinary health company, launched a new assay, endogenous ACTH (eACTH), for equine plasma on its TRUFORMA In-Clinic Biosensor Testing Platform. This assay allows equine veterinarians to diagnose and manage Cushing's Disease (pituitary pars intermedia dysfunction - PPID) conveniently at the clinic or stall. The eACTH assay provides reference-laboratory-level accuracy, supporting effective diagnosis and monitoring of horses with PPID, a common endocrine disorder in equines. Zomedica designed the TRUFORMA platform to meet the specific needs of equine practitioners, enhancing both patient care and practice efficiency.
In June 2023, Mars Incorporated, a US-based provider of pet nutrition, veterinary services, diagnostic solutions, and animal healthcare products, acquired Heska Corporation for $120.0 per share under a definitive agreement. Through this acquisition, Mars Petcare aimed to expand access to veterinary diagnostics and technology, accelerate R&D, and enhance its global point-of-care diagnostic capabilities within its Science & Diagnostics division, strengthening its position in the veterinary healthcare market. Heska Corporation is a US-based provider of veterinary point-of-care diagnostic instruments, in-clinic analyzers, consumables, and related software solutions for companion animal veterinarians.
Major companies operating in the veterinary point of care diagnostics market are IDEXX Laboratories Inc., Heska Corporation, Eurolyser Diagnostica GmbH, Anipoc Ltd., Alvedia, Bionote Inc., Mindray Bio‑Medical Electronics Co. Ltd., Thermo Fisher Scientific Inc., BioGal Galed Labs, MEGACOR Diagnostik GmbH, GeneReach, Quidel Corporation, Biopanda Reagents Ltd., Biochek BV, IDvet, Skyla Corporation, Fassisi GmbH, GE Healthcare, Esaote SpA, BioMerieux SA, Prometheus Bio Inc., Midland BioProducts.
North America was the largest region in the veterinary point of care diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary point of care diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the veterinary point of care diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have impacted the veterinary point-of-care diagnostics market by increasing costs for imported instruments, reagents, and consumables, which has affected product pricing and supply timelines. Companion animal and livestock segments in regions like North America and Europe are most affected due to dependency on imported diagnostic kits and analyzers. Positive impacts include boosting domestic manufacturing and encouraging local innovation in cost-effective point-of-care solutions, helping reduce reliance on imports over time.
The veterinary point of care diagnostics market research report is one of a series of new reports that provides veterinary point of care diagnostics market statistics, including veterinary point of care diagnostics industry global market size, regional shares, competitors with a veterinary point of care diagnostics market share, detailed veterinary point of care diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary point of care diagnostics industry. This veterinary point of care diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Veterinary point-of-care diagnostics play a vital role in real-time animal health assessment, delivering clinically relevant information during clinical practice without relying on laboratory results. This approach significantly reduces the turnaround time (TAT) for animal test results, aiding clinicians in promptly determining the appropriate treatment course for their patients.
The primary products within veterinary point-of-care diagnostics include consumables, reagents, kits, instruments, and devices. Consumables, reagents, and kits are utilized in the diagnosis of infectious and metabolic diseases in both companion and livestock animals. These products encompass substances consumed during testing, materials for preparing diagnostic products, and test kits used in various diagnostic technologies such as immunodiagnostics, clinical biochemistry, molecular diagnostics, hematology, urinalysis, and other related technologies. Veterinary point-of-care diagnostics find application in veterinary clinics, hospitals, academic institutes, and even home care settings for the benefit of animal health.
The veterinary point-of-care diagnostics market includes revenues earned by entities by hematology, diagnostic imaging, bacteriology, virology, cytology, clinical chemistry and parasitology. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The veterinary point of care diagnostics market size is expected to see rapid growth in the next few years. It will grow to $3.75 billion in 2030 at a compound annual growth rate (CAGR) of 13.3%. The growth in the forecast period can be attributed to adoption of portable diagnostic analyzers, integration of AI and IoT in veterinary diagnostics, growth in home care veterinary solutions, increasing investment in veterinary point-of-care R&D, expansion of molecular and biochemical diagnostic technologies. Major trends in the forecast period include increasing adoption of rapid diagnostic tools, rising demand for on-site testing solutions, expansion of companion animal health monitoring, integration of real-time data in veterinary care, growth of preventive veterinary diagnostics.
The rising companion animal population is expected to drive growth in the veterinary point-of-care diagnostics market in the coming years. Companion animals are pets that live in close proximity to humans. The increase in companion animal numbers is boosting demand for veterinary point-of-care diagnostics, which enable faster clinical decision-making in diagnosis, treatment selection, monitoring, prognosis, as well as operational and resource management. Veterinary point-of-care diagnostics support the companion animal population by providing rapid and accurate health assessments, allowing timely treatment and improved overall care. For example, in March 2025, according to the American Pet Products Association, a US-based national pet products trade organization, 94 million U.S. households owned at least one pet, up from 82 million in 2023, reflecting a significant rise in companion animal adoption. Therefore, the growing companion animal population is propelling the veterinary point-of-care diagnostics market.
Leading players in the veterinary point-of-care diagnostics market are developing innovative assays to maintain a competitive edge. Assays are diagnostic tests designed to detect specific biological markers, substances, or conditions associated with particular diseases. For instance, in September 2023, Zomedica Corp., a US-based veterinary health company, launched a new assay, endogenous ACTH (eACTH), for equine plasma on its TRUFORMA In-Clinic Biosensor Testing Platform. This assay allows equine veterinarians to diagnose and manage Cushing's Disease (pituitary pars intermedia dysfunction - PPID) conveniently at the clinic or stall. The eACTH assay provides reference-laboratory-level accuracy, supporting effective diagnosis and monitoring of horses with PPID, a common endocrine disorder in equines. Zomedica designed the TRUFORMA platform to meet the specific needs of equine practitioners, enhancing both patient care and practice efficiency.
In June 2023, Mars Incorporated, a US-based provider of pet nutrition, veterinary services, diagnostic solutions, and animal healthcare products, acquired Heska Corporation for $120.0 per share under a definitive agreement. Through this acquisition, Mars Petcare aimed to expand access to veterinary diagnostics and technology, accelerate R&D, and enhance its global point-of-care diagnostic capabilities within its Science & Diagnostics division, strengthening its position in the veterinary healthcare market. Heska Corporation is a US-based provider of veterinary point-of-care diagnostic instruments, in-clinic analyzers, consumables, and related software solutions for companion animal veterinarians.
Major companies operating in the veterinary point of care diagnostics market are IDEXX Laboratories Inc., Heska Corporation, Eurolyser Diagnostica GmbH, Anipoc Ltd., Alvedia, Bionote Inc., Mindray Bio‑Medical Electronics Co. Ltd., Thermo Fisher Scientific Inc., BioGal Galed Labs, MEGACOR Diagnostik GmbH, GeneReach, Quidel Corporation, Biopanda Reagents Ltd., Biochek BV, IDvet, Skyla Corporation, Fassisi GmbH, GE Healthcare, Esaote SpA, BioMerieux SA, Prometheus Bio Inc., Midland BioProducts.
North America was the largest region in the veterinary point of care diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary point of care diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the veterinary point of care diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have impacted the veterinary point-of-care diagnostics market by increasing costs for imported instruments, reagents, and consumables, which has affected product pricing and supply timelines. Companion animal and livestock segments in regions like North America and Europe are most affected due to dependency on imported diagnostic kits and analyzers. Positive impacts include boosting domestic manufacturing and encouraging local innovation in cost-effective point-of-care solutions, helping reduce reliance on imports over time.
The veterinary point of care diagnostics market research report is one of a series of new reports that provides veterinary point of care diagnostics market statistics, including veterinary point of care diagnostics industry global market size, regional shares, competitors with a veterinary point of care diagnostics market share, detailed veterinary point of care diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary point of care diagnostics industry. This veterinary point of care diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Veterinary point-of-care diagnostics play a vital role in real-time animal health assessment, delivering clinically relevant information during clinical practice without relying on laboratory results. This approach significantly reduces the turnaround time (TAT) for animal test results, aiding clinicians in promptly determining the appropriate treatment course for their patients.
The primary products within veterinary point-of-care diagnostics include consumables, reagents, kits, instruments, and devices. Consumables, reagents, and kits are utilized in the diagnosis of infectious and metabolic diseases in both companion and livestock animals. These products encompass substances consumed during testing, materials for preparing diagnostic products, and test kits used in various diagnostic technologies such as immunodiagnostics, clinical biochemistry, molecular diagnostics, hematology, urinalysis, and other related technologies. Veterinary point-of-care diagnostics find application in veterinary clinics, hospitals, academic institutes, and even home care settings for the benefit of animal health.
The veterinary point-of-care diagnostics market includes revenues earned by entities by hematology, diagnostic imaging, bacteriology, virology, cytology, clinical chemistry and parasitology. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Veterinary Point of Care Diagnostics Market Characteristics
3. Veterinary Point of Care Diagnostics Market Supply Chain Analysis
4. Global Veterinary Point of Care Diagnostics Market Trends and Strategies
5. Veterinary Point of Care Diagnostics Market Analysis of End Use Industries
7. Global Veterinary Point of Care Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Veterinary Point of Care Diagnostics Total Addressable Market (TAM) Analysis for the Market
9. Veterinary Point of Care Diagnostics Market Segmentation
10. Veterinary Point of Care Diagnostics Market Regional and Country Analysis
11. Asia-Pacific Veterinary Point of Care Diagnostics Market
12. China Veterinary Point of Care Diagnostics Market
13. India Veterinary Point of Care Diagnostics Market
14. Japan Veterinary Point of Care Diagnostics Market
15. Australia Veterinary Point of Care Diagnostics Market
16. Indonesia Veterinary Point of Care Diagnostics Market
17. South Korea Veterinary Point of Care Diagnostics Market
18. Taiwan Veterinary Point of Care Diagnostics Market
19. South East Asia Veterinary Point of Care Diagnostics Market
20. Western Europe Veterinary Point of Care Diagnostics Market
21. UK Veterinary Point of Care Diagnostics Market
22. Germany Veterinary Point of Care Diagnostics Market
23. France Veterinary Point of Care Diagnostics Market
24. Italy Veterinary Point of Care Diagnostics Market
25. Spain Veterinary Point of Care Diagnostics Market
26. Eastern Europe Veterinary Point of Care Diagnostics Market
27. Russia Veterinary Point of Care Diagnostics Market
28. North America Veterinary Point of Care Diagnostics Market
29. USA Veterinary Point of Care Diagnostics Market
30. Canada Veterinary Point of Care Diagnostics Market
31. South America Veterinary Point of Care Diagnostics Market
32. Brazil Veterinary Point of Care Diagnostics Market
33. Middle East Veterinary Point of Care Diagnostics Market
34. Africa Veterinary Point of Care Diagnostics Market
36. Veterinary Point of Care Diagnostics Market Competitive Landscape and Company Profiles
37. Veterinary Point of Care Diagnostics Market Other Major and Innovative Companies
40. Veterinary Point of Care Diagnostics Market High Potential Countries, Segments and Strategies
41. Appendix
Executive Summary
Veterinary Point Of Care Diagnostics Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses veterinary point of care diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for veterinary point of care diagnostics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The veterinary point of care diagnostics market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Consumables; Reagents And Kits; Instruments And Devices2) By Animal Type: Companion Animals; Livestock Animals
3) By Disease: Infectious Diseases; Metabolic Diseases; Other Diseases
4) By Technology: Immunodiagnostics; Clinical Biochemistry; Molecular Diagnostics; Hematology; Urinalysis; Other Technologies
5) By End User: Veterinary Clinics; Veterinary Hospitals And Academic Institutes; Home Care Settings
Subsegments:
1) By Consumables: Test Strips; Blood Collection Tubes; Urine Test Strips; Microbial Culture Media2) By Reagents And Kits: Enzyme-Linked Immunosorbent Assay (ELISA) Kits; PCR Reagents; Rapid Test Kits; Diagnostic Assay Kits
3) By Instruments And Devices: Portable Analyzers; Diagnostic Imaging Devices; Hematology Analyzers; Biochemical Analyzers
Companies Mentioned: IDEXX Laboratories Inc.; Heska Corporation; Eurolyser Diagnostica GmbH; Anipoc Ltd.; Alvedia; Bionote Inc.; Mindray Bio‑Medical Electronics Co. Ltd.; Thermo Fisher Scientific Inc.; BioGal Galed Labs; MEGACOR Diagnostik GmbH; GeneReach; Quidel Corporation; Biopanda Reagents Ltd.; Biochek BV; IDvet; Skyla Corporation; Fassisi GmbH; GE Healthcare; Esaote SpA; BioMerieux SA; Prometheus Bio Inc.; Midland BioProducts
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Veterinary Point of Care Diagnostics market report include:- IDEXX Laboratories Inc.
- Heska Corporation
- Eurolyser Diagnostica GmbH
- Anipoc Ltd.
- Alvedia
- Bionote Inc.
- Mindray Bio‑Medical Electronics Co. Ltd.
- Thermo Fisher Scientific Inc.
- BioGal Galed Labs
- MEGACOR Diagnostik GmbH
- GeneReach
- Quidel Corporation
- Biopanda Reagents Ltd.
- Biochek BV
- IDvet
- Skyla Corporation
- Fassisi GmbH
- GE Healthcare
- Esaote SpA
- BioMerieux SA
- Prometheus Bio Inc.
- Midland BioProducts
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 2.28 Billion |
| Forecasted Market Value ( USD | $ 3.75 Billion |
| Compound Annual Growth Rate | 13.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |
